Zynex, Inc. (ZYXI)
- Previous Close
8.19 - Open
8.27 - Bid 8.14 x 100
- Ask 8.22 x 200
- Day's Range
8.10 - 8.44 - 52 Week Range
7.04 - 13.77 - Volume
96,811 - Avg. Volume
150,626 - Market Cap (intraday)
259.654M - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
45.44 - EPS (TTM)
0.18 - Earnings Date Oct 24, 2024 - Oct 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jan 5, 2022
- 1y Target Est
17.75
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
www.zynex.com1,100
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ZYXI
View MorePerformance Overview: ZYXI
Trailing total returns as of 9/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZYXI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZYXI
View MoreValuation Measures
Market Cap
259.97M
Enterprise Value
304.05M
Trailing P/E
45.50
Forward P/E
16.37
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.43
Price/Book (mrq)
7.92
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
20.42
Financial Highlights
Profitability and Income Statement
Profit Margin
3.12%
Return on Assets (ttm)
4.80%
Return on Equity (ttm)
12.70%
Revenue (ttm)
193.61M
Net Income Avi to Common (ttm)
6.04M
Diluted EPS (ttm)
0.18
Balance Sheet and Cash Flow
Total Cash (mrq)
30.9M
Total Debt/Equity (mrq)
228.46%
Levered Free Cash Flow (ttm)
19.6M